Editor - Maha Abdeladhim | National Institute of Allergy and Inf | 19100

Journal of Clinical Infectious Diseases & Practice
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Maha Abdeladhim

Maha Abdeladhim
Maha Abdeladhim
National Inistitute of Health


MAHA ABDELADHIM is a Post-doctoral fellow at National Institutes of Allergy and Infectious Diseases (NIAID), Maryland, USA. In the Laboratory of Malaria and Vector Research, Vector Molecular Biology Section working on different aspect of using saliva from vector sand flies in different contexts; as Marker of exposure, as therapeutic molecules but mainly as a vaccine candidate against leishmaniasis. Dr. Abdeladhim received her Master degree in Microbiology/Immunology from the University of Mathematics, Physics and Naturals of Tunis in Tunisia in 2007 and Doctoral degree in Immunology from the same University in 2012. She was working on Human immune response to saliva of sand flies. She received her training in Pasteur Institute of Tunis. Apart from her main project on Immunity to saliva of sand flies she has been involved in many project related to Auto-Immune diseases. In addition, she has been teaching immunology and training students in the lab.

Research Interest

Dr. Abdeladhim’s research focuses on Immunity to saliva of sand flies, Auto-Immune diseases, Microbiology, Immunology Immunobiology of infections. Her objectives in the research of Immunity to saliva of sand flies are as follows: Primary objective is to characterize the cellular and humoral immune response against the saliva of sand flies in Human. Secondary objective is to determine which protein is immunogenic in human. Tertiary objective is to found the immunogenic protein inducing a protective immune response to be designed as vaccine against leishmaniasis.



Global Speakers in the subject

Global Experts in the subject